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ABSTRACT. Since its introduction, the subcutaneous implantable cardioverter-defibrillator
(S-ICD) has provided the benefit of reduced mortality from ventricular tachyarrythmias without
the associated short- and long-term morbidity of transvenous or epicardial implantable
cardioverter-defibrillator (ICD) leads. As its name implies, the S-ICD system is implanted in its
entirety, including device and lead, just under the skin beginning along the anterior axillary line,
with its lead tunneled to the left parasternum and then from the xiphoid to the manubrium–sternal
junction. Dislocation of the lead due to migration of the parasternal lead has been described in a
minority of patients. Here, we describe an unusual case of a significant lead migration in a pediatric
patient.
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Case presentation
The patient was a 16-year-old male with hypertrophic
cardiomyopathy (HCM) who initially presented to his
primary cardiologist after two episodes of syncope while
playing competitive basketball. He had a muscular build
including weight 86.9 kg (92nd percentile), stature 185.5 cm
(92nd percentile), and body mass index 29 (96th percentile).
His baseline electrocardiogram showed a sinus brady-
cardia at 51 bpm with massive left-ventricular hyper-
trophy and T-wave inversion in the lateral precordial
leads V4–V6 as well as II, III, and aVF. An echocardio-
gram showed asymmetric hypertrophy of the posterior
free wall and apex and normal diastolic intraventricular
wall thickness of 15 mm. He was initiated on metoprolol
XL and restricted from activities. Further evaluation included
a Holter monitor, exercise treadmill test and cardiac magnetic
resonance imaging, which demonstrated non-specific
atrial and ventricular ectopy, normal blood pressure
response, and no myocardial late gadolinium enhance-
ment, respectively. Genetic testing was similarly negative
for Class I and Class II mutations, although a Class III
mutation was present in the GLA gene. Despite the mixed
diagnostic studies, in the presence of unexplained syn-
cope and adequate clinical criteria for HCM, he was
referred for placement of a primary prevention ICD.
Upon referral to our office, we reviewed the clinical
indication for device placement and described the treat-
ment options including a transvenous single-chamber
single-coil ICD system and S-ICD system. Given the
patient and family’s interest in the S-ICD system, he
underwent electrode screening supine, sitting, standing
and while using a stationary bicycle. He was determined
to be an appropriate candidate for the S-ICD system.
The procedure was performed under general anesthesia
in the pediatric electrophysiology laboratory. Given the
patient’s large and muscular build, we elected to per-
form a three-incision technique rather than a two-incision
to provide additional lead support. Therefore, a 6-cm
incision was made just inferior to the subpectoral groove
to the anterior axillary line. A pocket was formed from
the incision cranially and laterally, reaching the left
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mid-axillary line. A vertical 3-cm incision was made at
the left parasternal border at the level of the xiphoid process,
exposing the fascia overlying the sternal periostium.
The tunneling tool was used to connect this incision to
the generator pocket. The lead was then connected to
the tunneling tool with a silk tie and pulled from the
generator pocket to the xiphoid pocket. The lead was
secured to the chest wall fascia with a suture sleeve and a
horizontal 3-cm incision was then made at the left upper
sternal border to expose the fascia overlying the sternal
periostium. The tunneling tool was then used to connect
the inferior pocket to the lead tip pocket and the lead was
pulled through to the superior position. The lead pockets
were sutured closed, and the lead was connected to the
generator. Sensing vectors were tested and the config-
uration was set at the alternate vector. Defibrillation
testing was successful on the first treatment of 65 J. The
device was programmed with a conditional shock zone
220 bpm and shock zone 240 bpm, and skin closures
were then completed. The patient was moved to the post-
anesthesia care unit in stable condition. A post-surgical
anterior–posterior (AP) projection chest X-ray was com-
pleted, which showed stable positioning of the device
and lead. The following morning, a repeat (posterior–
anterior) PA chest X-ray showed the tip of the lead at
roughly the seventh rib consistent with the fluoroscopic
positioning from the prior day (Figure 1).
The patient was evaluated in the emergency department
(ED) for a non-specific fever approximately 10 days after
the procedure. The work-up was unremarkable, with even-
tual resolution of the fever and a non-concerning surgical
site. An X-ray obtained during this visit showed stable
location of the device and leads. The patient was dis-
charged with a routine follow-up schedule ordered.
The patient was seen six weeks later for routine follow-
up, where he reported an ongoing feeling of contact
between the device and his left scapula upon upward
stretching of his left arm, as well as a specific episode of
stretching during which he felt a tug from his sternum to
the left axilla and then relief of the pulling sensation. This
episode had occurred some time after he was evaluated
in the ED for fever. A chest X-ray performed at this time
showed that the lead had migrated from a purely vertical
position to a hockey stick right contour with a displace-
ment of approximately 4.5 cm with the tip overlying rib 9
(Figure 2). Evaluation of the patient’s device demon-
strated adequate sensing, though with a change in the
optimal vector from alternate to secondary. The sensing
configuration was changed to the secondary vector and
the decision was made to obtain a chest X-ray in four
weeks for evidence of any continued lead migration.
Owing to social developments, the chest radiograph was
not completed at that time. Follow-up after an addi-
tional 2 months showed further regression of the lead
with the lead tip sitting at approximately 6.5 cm below its
original position with an increased L-shaped configura-
tion of the high voltage coil (Figure 3). Again, vector
analysis showed adequate sensing with no change in
lead impedance. Despite a continued lack of symptoms
and arrhythmias, based on the continued movement of
the lead, there was a growing question of progressive
failure to sense. Moreover, no data regarding defibrilla-
tion success was available with the new position. As
such, the decision was made to reposition the lead.
The patient was taken back into the operating room
for lead revision approximately 5 months following the
initial system placement. We incised the inferior and
superior sternal scars and dissected down to the fascia
overlying the periosteum. The tip of the lead was not
present at the upper incision, nor was the suture sleeve
present at the lower. Retained non-absorbable suture
material tied to the fascia was present at both sites.
Figure 1: Note the proper post-surgical positioning of the
lead.
Figure 2: Chest X-ray showing lead migration with displace-
ment of approximately 4.5 cm.
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The tip of the lead was withdrawn to the lower incision
and fully extended. The suture sleeve was not visible and
presumably retained proximal to the lower incision site.
At this time, the tip of the lead was secured to a new
tunneling tool and extended to the superior incision. Its
placement was verified with fluoroscopy and the lead tip
was then secured at the superior incision site with two
non-absorbable stay sutures and the proximal electrode
secured with a new suture sleeve and two non-absorbable
stay sutures as well. The pockets were then closed in the
usual fashion. The sensing vector of choice returned
to the alternative vector. Defibrillation testing was not
repeated given the prior success of leads and device
in the same positions as confirmed by radiography. The
patient tolerated the procedure without difficulty and
recovered without any fever, pain, swelling, or indura-
tion. He limited his activities overall per standard HCM
precautions as well as with specific emphasis to avoid acti-
vities of the upper extremity to avoid further dislodge-
ment of the lead until adequate healing had taken place.
The patient returned for a routine follow-up visit ap-
proximately five weeks after the lead revision. An
examination showed healing incisions at the manubrium
and xiphoid process. The lateral incision was also well-
healed and the subcutaneous ICD lead and device were
palpated and in place. Interrogation of the device showed
no treated or untreated episodes of ventricular tachy-
cardia. A chest X-ray showed stable placement of both
the lead and generator.
Discussion
Children and young adults with a history of cardiac arrest,
refractory ventricular tachycardia or high risk of sudden
cardiac death may benefit from the implantation of an
ICD, and children overall have appropriate rates of
discharge comparable to the adult population.1 How-
ever, ICD placement in the pediatric patient may be more
challenging due to expected life span requiring long-term
device integrity, expected growth and activity level, and/
or coexisting congenital heart disease or cardiomyopathy.
Transvenous or epicardial ICD in particular carries a risk
of long-term intravascular lead complications, including
infection, insulation damage and conductor coil break-
age.2 Other perioperative and postoperative complica-
tions such as lead dislodgement, pneumothorax, cardiac
perforation and pericardial effusions have also been
described.2 Moreover, ICD implantation in the pediatric
population may be limited by patient size, venous anat-
omy and/or cardiac anatomy.3 In children of adult size, a
two-incision technique may be employed to implant the
S-ICD, thereby avoiding the superior parasternal inci-
sion. However, a three-incision technique was employed
for this particular patient given his large and muscular
build, in hopes of providing additional lead support
during the scarring process. Despite this modification,
however, the lead position moved.
S-ICD systems were developed to minimize the risks
associated with transvenous and epicardial ICD place-
ment. Because of their subcutaneous extrathoracic loca-
tion, there is no lead placed in or on the heart. Therefore,
S-ICD devices cannot provide antitachycardia pacing,
advanced diagnostic or interrogation capabilities.2 Adverse
events of S-ICD include pocket infection, skin erosion
and need for lead revision.
Leadmigration has been described in a minority of patients
who have undergone S-ICD placement (Tables 1 & 2).2,4-12
When reported, these lead migrations appear to be within
1 cm to 2 cm of the original location, or along the para-
sternal border. There are very limited reports of pediatric
S-ICD placement and, to our knowledge, there are no
described cases of significant lead migration in a pedi-
atric patient.
Options for the management of lead migration include
observation at regular intervals, more frequent follow-up
with device testing and/or repositioning of the subcu-
taneous lead back to their original location. It is unclear if
repositioning is necessary if vector analysis and imped-
ance are adequate.
In this case, the gradual movement of the lead to a hori-
zontal plane 6.5 cm away from its original location raised
concern of additional movement. Although device test-
ing indicated adequate vectors, it was unclear if at some
point the vectors would become inadequate for proper
sensing and defibrillation. The adolescent’s parents were
also appropriately concerned about the location of the lead,
and provided input into the management decision.
Patients are advised to limit arm movement for approxi-
mately 7 to 10 days following placement of an S-ICD.
Adherence to this recommendation could be difficult for
the pediatric population overall, and particularly in the
case of younger children. In this instance, both the end
and stay sutures failed secondary to considerable lead
tension during patient stretching. Therefore, clinicians,
particularly pediatric cardiologists, should be familiar
with this possible adverse event.
Figure 3: Further regression of the lead to a more L-shaped
configuration.
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